Zimmer Biomet Holdings Revenue 2010-2024 | ZBH
Zimmer Biomet Holdings annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Zimmer Biomet Holdings revenue for the quarter ending September 30, 2024 was $1.824B, a 4.03% increase year-over-year.
- Zimmer Biomet Holdings revenue for the twelve months ending September 30, 2024 was $7.595B, a 4.34% increase year-over-year.
- Zimmer Biomet Holdings annual revenue for 2023 was $7.394B, a 6.55% increase from 2022.
- Zimmer Biomet Holdings annual revenue for 2022 was $6.94B, a 1.65% increase from 2021.
- Zimmer Biomet Holdings annual revenue for 2021 was $6.827B, a 11.42% increase from 2020.
| Zimmer Biomet Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $7,394 |
| 2022 | $6,940 |
| 2021 | $6,827 |
| 2020 | $6,128 |
| 2019 | $7,982 |
| 2018 | $7,933 |
| 2017 | $7,803 |
| 2016 | $7,668 |
| 2015 | $5,998 |
| 2014 | $4,673 |
| 2013 | $4,623 |
| 2012 | $4,472 |
| 2011 | $4,452 |
| 2010 | $4,220 |
| 2009 | $4,095 |
| Zimmer Biomet Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,824 |
| 2024-06-30 | $1,942 |
| 2024-03-31 | $1,889 |
| 2023-12-31 | $1,940 |
| 2023-09-30 | $1,754 |
| 2023-06-30 | $1,870 |
| 2023-03-31 | $1,831 |
| 2022-12-31 | $1,825 |
| 2022-09-30 | $1,670 |
| 2022-06-30 | $1,782 |
| 2022-03-31 | $1,663 |
| 2021-12-31 | $1,777 |
| 2021-09-30 | $1,685 |
| 2021-06-30 | $1,763 |
| 2021-03-31 | $1,601 |
| 2020-12-31 | $1,188 |
| 2020-09-30 | $1,929 |
| 2020-06-30 | $1,226 |
| 2020-03-31 | $1,784 |
| 2019-12-31 | $2,126 |
| 2019-09-30 | $1,892 |
| 2019-06-30 | $1,989 |
| 2019-03-31 | $1,976 |
| 2018-12-31 | $2,071 |
| 2018-09-30 | $1,837 |
| 2018-06-30 | $2,008 |
| 2018-03-31 | $2,018 |
| 2017-12-31 | $2,068 |
| 2017-09-30 | $1,813 |
| 2017-06-30 | $1,950 |
| 2017-03-31 | $1,972 |
| 2016-12-31 | $1,998 |
| 2016-09-30 | $1,833 |
| 2016-06-30 | $1,934 |
| 2016-03-31 | $1,904 |
| 2015-12-31 | $1,934 |
| 2015-09-30 | $1,762 |
| 2015-06-30 | $1,168 |
| 2015-03-31 | $1,134 |
| 2014-12-31 | $1,223 |
| 2014-09-30 | $1,106 |
| 2014-06-30 | $1,183 |
| 2014-03-31 | $1,162 |
| 2013-12-31 | $1,241 |
| 2013-09-30 | $1,074 |
| 2013-06-30 | $1,170 |
| 2013-03-31 | $1,139 |
| 2012-12-31 | $1,181 |
| 2012-09-30 | $1,026 |
| 2012-06-30 | $1,125 |
| 2012-03-31 | $1,141 |
| 2011-12-31 | $1,167 |
| 2011-09-30 | $1,032 |
| 2011-06-30 | $1,137 |
| 2011-03-31 | $1,116 |
| 2010-12-31 | $1,135 |
| 2010-09-30 | $965 |
| 2010-06-30 | $1,058 |
| 2010-03-31 | $1,063 |
| 2009-12-31 | $1,107 |
| 2009-09-30 | $976 |
| 2009-06-30 | $1,020 |
| 2009-03-31 | $993 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.316B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $206.001B | 26.28 |
| Stryker (SYK) | United States | $149.494B | 33.69 |
| Boston Scientific (BSX) | United States | $133.617B | 38.42 |
| EssilorLuxottica (ESLOY) | France | $111.202B | 0.00 |
| Medtronic (MDT) | Ireland | $110.969B | 16.48 |
| Haleon (HLN) | United Kingdom | $43.728B | 28.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.249B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $38.021B | 19.72 |
| ResMed (RMD) | United States | $36.555B | 30.04 |
| Terumo (TRUMY) | Japan | $30.395B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $25.604B | 19.60 |
| Insulet (PODD) | United States | $18.713B | 74.52 |
| Baxter (BAX) | United States | $17.212B | 11.20 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.271B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.104B | 40.65 |
| Bio-Rad Laboratories (BIO) | United States | $9.534B | 32.40 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.207B | 14.42 |
| Haemonetics (HAE) | United States | $4.393B | 21.44 |
| Prestige Consumer Healthcare (PBH) | United States | $4.188B | 20.83 |
| ICU Medical (ICUI) | United States | $4.014B | 38.22 |
| Perrigo (PRGO) | Ireland | $3.894B | 11.46 |
| Envista Holdings (NVST) | United States | $3.836B | 28.58 |
| Agios Pharmaceuticals (AGIO) | United States | $3.387B | 0.00 |
| Neogen (NEOG) | United States | $3.073B | 35.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.867B | 18.39 |
| QuidelOrtho (QDEL) | United States | $2.758B | 17.75 |
| LeMaitre Vascular (LMAT) | United States | $2.406B | 58.46 |
| Green Thumb Industries (GTBIF) | United States | $1.966B | 34.41 |
| AtriCure (ATRC) | United States | $1.763B | 0.00 |
| InMode (INMD) | Israel | $1.640B | 9.86 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.432B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.350B | 9.64 |
| BioLife Solutions (BLFS) | United States | $1.274B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.252B | 0.00 |
| Owens & Minor (OMI) | United States | $1.039B | 8.11 |
| CeriBell (CBLL) | United States | $1.031B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.953B | 31.84 |
| Phibro Animal Health (PAHC) | United States | $0.947B | 16.69 |
| Evolus (EOLS) | United States | $0.867B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.864B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 30.33 |
| Omeros (OMER) | United States | $0.658B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.576B | 0.00 |
| Surmodics (SRDX) | United States | $0.565B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.504B | 0.00 |
| Quanterix (QTRX) | United States | $0.473B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.465B | 0.00 |
| ZimVie (ZIMV) | United States | $0.407B | 34.33 |
| Biote (BTMD) | United States | $0.359B | 7.87 |
| Cerus (CERS) | United States | $0.344B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.338B | 32.11 |
| Valneva SE (VALN) | France | $0.329B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 19.00 |
| Zynex (ZYXI) | United States | $0.265B | 55.47 |
| High Tide (HITI) | Canada | $0.262B | 108.67 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.229B | 0.00 |
| MacroGenics (MGNX) | United States | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.28 |
| Sanuwave Health (SNWV) | United States | $0.179B | 2.52 |
| Brainsway (BWAY) | Israel | $0.165B | 98.70 |
| Organigram Holdings (OGI) | Canada | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 19.50 |
| Jin Medical (ZJYL) | China | $0.141B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.139B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.76 |
| Veru (VERU) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.076B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.074B | 38.17 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.068B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Modular Medical (MODD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.95 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |